An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Archived NCCN Tumor Boards: Hereditary Gastrointestinal Cancers - Expansion of NCCN Recommendations 1.00 12/06/2025 - 12:00am to 12/01/2026 - 12:00am
NCCN Guidelines® Insights - Soft Tissue Sarcoma, Version 1.2025 1.00 12/10/2025 - 12:00am to 12/10/2026 - 11:59pm
Recorded Presentations from the NCCN 2025 Lung Cancer Congress 12/15/2025 - 12:00am to 11/06/2026 - 11:59pm
Recorded Presentation from Optimizing Patient Outcomes - Smoking Cessation: To Vape or Not to Vape? 1.00 12/18/2025 - 12:00am to 12/09/2026 - 11:59pm
Recorded Presentation from Optimizing Patient Outcomes - The Changing Treatment Paradigm for Mantle Cell Lymphoma: Improving the Prognosis with... 1.00 12/19/2025 - 12:00am to 12/17/2026 - 11:59pm
NCCN Guidelines® Insights - Small Cell Lung Cancer, Version 2.2026 1.00 01/10/2026 - 12:00am to 01/10/2027 - 11:59pm
Behind the Guidelines: Insights into the Standard of Care in Oncology 2026 (NCCN Guidelines® Insights 2026) 01/10/2026 - 12:00am to 12/31/2027 - 11:59pm
NCCN Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology 01/21/2026 - 12:00am to 12/30/2027 - 11:59pm
Archived NCCN Tumor Boards: Challenges in Management of Chronic Lymphocytic Leukemia-Richter Transformation 1.00 02/05/2026 - 12:00am to 01/26/2027 - 11:59pm
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026 1.00 02/10/2026 - 12:00am to 02/10/2027 - 11:59pm
Archived NCCN Tumor Boards: Optimizing Treatment of Chronic Phase Chronic Myeloid Leukemia 1.00 03/09/2026 - 12:00am to 02/24/2027 - 11:59pm
NCCN Guidelines® Insights - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026 1.00 03/10/2026 - 12:00am to 03/10/2027 - 11:59pm
Recorded Presentations from the NCCN 2026 Breast Cancer Congress with Updates from the 2025 San Antonio Breast Cancer Symposium 03/15/2026 - 12:00am to 03/14/2027 - 11:59pm
NCCN Optimizing Patient Outcomes - From Mutation to Treatment: Understanding the Impact of New Targeted Therapies in Central Nervous System Cancers 1.00 04/01/2026 - 12:00am to 09/11/2026 - 11:59pm
NCCN Guidelines® Insights - Merkel Cell Carcinoma, Version 1.2024 (JA copy) 1.00 04/01/2026 - 12:00am to 12/31/2026 - 11:59pm

Pages